Comprehensive Case Management Reassessment



Similar documents
Comprehensive Case Management Reassessment

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily

GENERAL INSTRUCTIONS FOR COMPLETING THE HIV TEST FORM

HIV 1. A reference guide for prescription HIV-1 medications

Presented by: Canadian Working Group on HIV and Rehabilitation

Treatment Information Service HIV 0440 HIV/AIDS. HIV and Its Treatment What You Should Know. 2nd edition

Covered California s 2016 Formularies

Drug Treatment Program Update

HIV and the Central Nervous System: neurocognitive aspects VIH y Sistema Nervioso Central: aspectos neurocognitivos

Helpful HIV Medication Tables for Pharmacists

862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 1. Recreational Drugs and HIV Antiretrovirals. A Guide to Interactions for Clinicians

Systematic literature search: PICO questions

CO-PAY PROGRAMS FOR HIV and Hepatitis

FARMACI, INNOVAZIONE e INFEZIONE DA HIV / AIDS

The Antiretroviral. Pregnancy Registry. Interim Report VOL. 28, NO. 1 1 JANUARY 1989 THROUGH 31 JANUARY Interim Report. (Issued: June 2016)

Marketplace Health Plans Template Assessment Tool October 2014

Antiretroviral therapy for HIV infection in infants and children: Towards universal access

CDC occupation Codes used to code ( map ) facility locations

HIV Update: Epidemiology and Pathophysiology

1/26/2015. Epidemiology of the Epidemic: World. Epidemiology of the Epidemic: United States. HIV Update: Epidemiology and Pathophysiology

Theonest Ndyetabura KILIMANJARO CHRISTIAN MEDICAL CENTRE / KILIMANJARO CLINICAL RESERCH

North Carolina Marketplace Plans with More Affordable Drug Cost Sharing for People with HIV

AIDS ACCESS FOUNDATION/ MSF AIDS can be Treated: A handbook of Antiretroviral medicines. AIDS Can Be Treated. A Hand Book of Antiretroviral medicines

Antiretroviral Patient Medication Information Sheets Table of Contents

Generic antiretrovirals in Europe: a blessing or a curse?

ACA Insurance Enrollment for People living with HIV in North Carolina

A Guide to Primary Care of People with HIV/AIDS

It s In The Cards: Pharmaceutical Co-pay and Patient Assistance Programs. Jeff Berry Editor, Positively Aware

A Guide to Primary Care of People with HIV/AIDS

NON-OCCUPATIONAL POST EXPOSURE PROPHYLAXIS FOR SEXUAL ASSAULT SURVIVORS. Carl LeBuhn, MD

Chemotherapy regimen: Dose adjusted EPOCH

HIV/AIDS 2014 REPORT MEDICINES IN DEVELOPMENT. Contents. Medicines and Vaccines in Development for HIV Infection

Chapter 3 South African guidelines and introduction to clinical cases

National Antiretroviral Treatment Guidelines for Adults, Adolescents, and Children

Regulatory Approach in Germany and in the EU to Fixed Dose Combination Medicinal Products Using HIV/AIDS Treatment as an Example

Patent Expiry Impact Predictor

Social and Economic costs of HIV and AIDS. Current issues. Sarah Ann Adomakoh. Costs, cost-effectiveness & Sustainability

Combination Anti-Retroviral Therapy (CART) - Rationale and Recommendation. M Dinaker. Fig.1: Effect of CART on CD4 and viral load

London Therapeutic Tender Implementation: Guidance for Clinical Use. 4 th June 2014 FINAL

Antiretroviral Treatment

Management of HIV and TB Co-infection in South Africa

Bristol-Myers Squibb and Gilead Sciences, LLC 50

AfricanEyeVOICE. Meet the world s strongest HIV Positive Campaigner: Milly Katana. plus Treatment News Treatment Q&A History of HIV and much more...

HIV. Head - Paediatric HIV Treatment Programmes. Right to Care. Dr Leon Levin

People living. Since the start of the AIDS epidemic, more than 78 million people have been infected with HIV and 39 million have died (1).

UPDATE IN HIV POST-EXPOSURE PROPHYLAXIS. Weerawat Manosuthi

Prioritizing Second-Line Antiretroviral Drugs for Adults and Adolescents: a Public Health Approach

THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2013

Ryan White Program Services Definitions

The prevalence of transmitted antiretroviral drug resistance in treatment-naïve patients and factors influencing firstline treatment regimen selection

ACT. Advocacy for Community Treatment ITPC. Strengthening Community Responses to HIV Treatment and Prevention

Access and coverage of antiretroviral drugs through Canada s provincial and territorial drug programs

VILMA M. VEGA, M.D. CURRICULUM VITAE

Chapter 36. Media Directory. Characteristics of Viruses. Primitive Structure of Viruses. Therapy for Viral Infections. Drugs for Viral Infections

Post-Exposure Prophylaxis after Non-Occupational and Occupational exposure to HIV. National Guidelines

Republic of Namibia. Ministry of Health and Social Services Directorate of Special Programmes

National Antiretroviral Treatment Guidelines

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

ARV treatment Update Avondseminarie 18 december 2012 Eric Florence ITG, Antwerpen

Ryan White Part A Quality Management

From Drug Holidays to 100% Adherence- The Role of the Pharmacist in HIV Drug Therapy - FL APPROVED -

Transcription:

Comprehensive Case Management Reassessment Reassessment Date: Date of previous Assessment/Reassessment: Name: Client ID # Address: If Reassessment early or late explain: Current HIV Status: Asymptomatic Symptomatic AIDS At Risk CD4 Count: Date: Viral Load: Date: Method of Verification: Describe client s current situation: Emergency Contact: Phone # Relationship: Aware of Status? Y N Is there a Release of Information? Y N Date of Release: Address: 1

List all Service Providers that were involved in the last 180 days: Agency Type of Service Contact Phone # Case Conference Date Release of Information Expiration Date Identify Client s Collaterals/Children: *If any new children (under the age of 21) have moved into the household in the last 180 days, complete Child Assessment. Children s to Aware of Date Children s In Household Assessment Name Relationship Household Status Assessment Y/N Completed Y/N Y/N Completed Y/N 2

NEEDS REASSESSMENT For each area, review client s current status, and comment on any changes in client s functioning, needs and resources. Where appropriate, include information about the family support system. Comment on all areas checked and identify progress on goal areas for the previous quarter. Provide a brief summary for each section. * = not previously addressed; client not ready; in process; or, other with detailed information. HEALTH CARE * ed Primary Health Care Provider Identify: Date of last primary care appointment: Is client keeping appointments with primary care provider? Y N Inconsistent : Means of Verification: Current Hospital Preference: Complementary/Alternative Therapies Clinical Trials TB Testing/Treatment OB/GYN Identify Provider: Date of Last Exam: Date of last PAP: Test Results: Is Client Pregnant? Yes No Due Date: If yes, is client receiving prenatal care? Yes No If yes, has AZT Therapy been discussed? Yes No Family Planning STD Testing/Treatment 3

HEALTH CARE * ed Hepatitis Testing/Treatment Home Care Hospice Nutrition Dental Vision Other: (Fill in spaces below) Medications Identify current medication See next page specifically for medication Does client have access to medication? Y N Inconsistent If No or Inconsistent, : Does client need education in this area? Y N : 4

MEDICATIONS: Is client adhering to HIV medication regimen? Y N Inconsistent Unclear : Is assistance needed? Y N Identify: Antiretroviral medications Protease Inhibitors (PI) Date Started Dosage/Frequency Agenerase (amprenavir, APV) Aptivus (tipranavir, TPV) Crixivan (idinavir, IDV) Fortovase (saquinavir, SQV-soft gel cap) Invirase (saquinavir, SQV- hard gel cap) Kaletra (lopinavir/ritonavir, LPV/r) Lexiva (fosamprenavir, FPV) Norvir (ritonavir, RTV) Reyataz (atazanavir, ATV) Viracept (nelfinavir, NFV) Non Nucleoside Reverse Transcriptase Inhibitors (nnrti) Date Started Dosage/Frequency Rescriptor (delavirdine, DLV) Sustiva (efavirenz, EFV) Viramune (nevirapine, NVP) Nucleoside/nucleotide Reverse Transcriptase Inhibitors (NRTI) Date Started Dosage/Frequency Combivir (zidovudine + lamivudine, AZT + 3TC) Emtriva (emtricitabine, FTC) Epivir (lamivudine, 3TC) Epzicom (abacavir + lamivudine, ABC + 3TC) Hivid (zalcitabine, ddc) Retrovir (zidovudine, AZT or ZDV) Trizivir (abacavir + zidovudine + lamivudine, ABC + AZT + 3TC) Truvada (tenofovir + emtricitabine, TDF + FTC) VIDEX (didanosine, ddi) VIDEX EC (didanosine:delayed-release capsules, ddi) Viread (tenofovir DF, TDF) Zerit (stavudine, d4t) Zerit XR (stavudine:delayed-release, d4t) Ziagen (abacavir, ABC) Entry / Fusion Inhibitors Date Started Dosage/Frequency Fuzeon (enfuvirtide, ENF) The AIDS Institute updates the Medication List form on a quarterly basis for use with assessments and reassessments. This page should be replaced with an the most recent copy of the updated medication list. 5

OTHER MEDICATIONS (All other medications including TB, Psychotropic, etc.) Is client adhering to HIV medication regimen? Y N Inconsistent Unclear : Is assistance needed? Y N Identify: Name Date Started Dosage/Frequency 6

HEALTH CARE continued Collateral (especially children) Status/s: Current Overall Status/Barriers: 7

FINANCIAL/ ENTITLEMENTS * ed (Include $ Amounts) Food Stamps Medicaid ADAP SSI/SSD/VA Benefits Unemployment Benefits Home Relief/Safety Net TANF DAS (LDSS) Rent Enhancement Financial Management Other: (Fill in Section Below) If on MA spend down, Identify amount: Indicate methods of spend down: Current Overall Status/s: 8

INDEPENDENT LIVING Date of most recent home: visit: * ed Current housing status: Permanent Transitional Homeless Describe: Appropriate/Affordable Eviction ice Owes Back Rent Housing Repairs ed Advocacy with Landlord Out of Pocket Rent Expense Utilities Phone Transportation Other: Current Overall Status/Barriers: 9

SUBSTANCE USE * ed Is client currently using substances? Yes No (What/How Much/How Often): Out Patient Treatment Residential Treatment MMTP (Dosage ) AA/NA Meetings DETOX le Exchange Other: (Fill in section below) If yes to any of the above, indicate frequency: Does client keep scheduled appointments: Yes No Inconsistent Current Overall Status/Barriers: 10

MENTAL HEALTH Psychiatric Care Identify Provider: * ed Identify psychotropic medication (These should be included on Medication page): Is client adhering to psychotropic medication regimen? Y N Inconsistent Individual/Family Counseling Support Group Bereavement Counseling Religious Support If yes to any of the above, indicate frequency: Does client/family keep scheduled appointments: Yes No Inconsistent Is client involved in any recreational/social activity: Yes No Inconsistent : Other: Current Overall Status/Barriers: 11

FAMILY STABILITY Children s Service s: Medical Educational Developmental Emotional Social Client/Collateral Service s: Guardianship/ Permanency Planning Child Abuse/Neglect Parenting Skills Child Care Respite Disclosure Domestic Violence Partner/Spousal ification * ed Is client linked with support systems? Yes No Inconsistent Identify: Other: Current Overall Status/Barriers: 12

LEGAL Legal Rights/Discrimination Will Living Will Health Care Proxy DNR Power of Attorney Criminal Justice Parole/Probation Immigration/Naturalization * ed Is client/family keeping legal appointments? Yes No Inconsistent Other: Current Overall Status/Barriers: 13

EMPLOYMENT/ EDUCATION GED/Education Job Readiness Assessment Job Training Job Placement Volunteer/Stipend * ed Has client returned to work or joined the workforce for the first time? Yes No If yes, PT/FT (> 20h/week): Other: Current Overall Status/Barriers: 14

PREVENTION EDUCATION REVIEW Date: * Discussion in all areas is required unless referral is made. Topic Referral ed Y/N HIV TB Hepatitis (A, B,C)/Vaccines STD Safer Sex Condoms Spermicide Dental Dam Drug Use le Sharing Use of Bleach Other Harm Reduction Techniques Universal Precautions Does client report consistent adherence to safer sex/harm reduction guidelines? Yes No Inconsistent Other: Current Overall Status/Barriers: 15

Ability to Perform Activities of Daily Living: If Assistance is Required, Recommended Care Environment: Who Currently Assists? Feeding 0 1 2 Home Ambulating 0 1 2 Alone Transferring 0 1 2 Family Grooming 0 1 2 Other Dressing 0 1 2 Home with Support Bathing 0 1 2 Homemaking Toileting 0 1 2 Personal Care Homemaking 0 1 2 Skilled Nursing Financial Management 0 1 2 Hospital Preparing Meals 0 1 2 Nursing Home Taking Medicine 0 1 2 Supportive Housing Grocery Shopping 0 1 2 Hospice Traveling 0 1 2 ADHC Using Telephone 0 1 2 Other Decision Making 0 1 2 0 = By Self 1 = Some Assistance 2 = Total Assistance Other identified client/support system service needs or issues which need to be addressed: 16

Summary Comments/General Status of Client/Family: Indicate client s level of participation in goal achievement over the past quarter: Case Manager Signature Date Supervisor Signature Approval Date 17